ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2015
The Patient Activation Measure: a validation study in a neurological population.
Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Rasch analysis on the patient activation measure among people with spinal cord injury in China.Spinal cord · 2026Article
- The Patient Reported Inventory of Self-Management of Chronic Conditions (PRISM-CC): testing for bias across patient characteristics and languages.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Validation of the Patient Activation Measure (PAM-13) among individuals with chronic spinal cord injury in mainland China.The journal of spinal cord medicine · 2026Article
- Factors associated with patient activation among patients with diabetes on hemodialysis: a multicenter cross-sectional study from a developing country.BMC nephrology · 2024Article
- A Systematic Review of the Reliability and Validity of the Patient Activation Measure Tool.Healthcare (Basel, Switzerland) · 2024Review
- The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation.Health and quality of life outcomes · 2024Article
- Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024Article
- Text messaging intervention for fatigue self-management in people with stroke, spinal cord injury, and multiple sclerosis: A pilot study.Disability and health journal · 2024Article
- Quality of life in caregivers of a child with a developmental and epileptic encephalopathy.Developmental medicine and child neurology · 2024Article
- Application of the PAPERS Grading Criteria Within a Rapid Evidence Review to Determine the Psychometric and Pragmatic Properties of Patient Empowerment Tools.Journal of patient experience · 2024Article
- Response Category Functioning on the Health Care Engagement Measure Using the Nominal Response Model.Assessment · 2023Article
- Factor structure and internal consistency of the parent patient activation measure (P-PAM) in parents of children with ADHD in norwegian paediatric mental health.BMC psychiatry · 2023Article
- Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above.The European journal of health economics : HEPAC : health economics in prevention and care · 2022Article
- Article
- Patient Activation Among Prevalent Hemodialysis Patients: An Observational Cross-Sectional Study.Journal of patient experience · 2022Article
- COVID-19 social distancing: negative effects on people with Parkinson disease and their associations with confidence for self-management.BMC neurology · 2021Article
- Article
- Is the Patient Activation Measure a valid measure of osteoarthritis self-management attitudes and capabilities? Results of a Rasch analysis.Health and quality of life outcomes · 2020Article
- Validity and reliability of the Patient Activation Measure® (PAM®)-13 Malay version among patients with Metabolic Syndrome in primary care.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2020Article
- Validation of the patient activation measure in patients at discharge from hospitals and at distance from hospital care in Sweden.BMC public health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the validity of the Patient Activation Measure (PAM13) of patient activation in persons with neurological conditions.
methods"The Everyday Experience of Living with and Managing a Neurological Condition" (The LINC study) surveyed 948 adults with neurological conditions residing in Canada in 2011 and 2012. Using data for 722 respondents who met coding requirements for the PAM-13, we examined the properties of the measure using principle components analysis, inter-item correlations and Cronbach's alpha to assess unidimensionality and internal consistency. Rasch modeling was used to assess item performance and scaling. Construct validity was assessed by calculating associations between the PAM and known correlates.
resultsPAM-13 provides a suitably reliable and valid instrument for research in patients with neurological conditions, but scaling problems may yield measurement error and biases for those with low levels of activation. This is of particular importance when used in clinical settings or for individual client care. Our study also suggests that measurement of activation may benefit from tailoring items and scaling to specific diagnostic groups such as people with neurological conditions, thus allowing the PAM-13 to recognize unique attributes and management challenges in those conditions.
conclusionsThe PAM-13 is an internally reliable and valid tool for research purposes. The use of categorical activation "level" in clinical settings should be done with caution.
Indexed as
Identifiers
25557496What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.